Fact sheet
| CEO | Andrin Oswald |
| Headquarters | Cambridge, Massachusetts, USA |
| Major R&D sites | Cambridge, Massachusetts, USA |
| Emeryville, California, USA | |
| Siena, Italy |
| Major production sites | Ankelshwar, India |
| Holly Springs, North Carolina, USA | |
| Siena/Rosia, Italy | |
| Marburg, Germany | |
| Liverpool, England |
| Web site address |
| 2009 net sales | USD 2.5 billion |
| 2009 full-time associates |
5416 |
| Leading products | |
| Influenza and Pandemic A(H1N1) | Agriflu/Agrippal Begrivac Celtura Fluad Focetria Fluvirin Optaflu |
| Meningitis | Menjugate Menveo |
| Pediatric/Traveler | Encepur Ixiaro Polioral Quinvaxem Rabipur/Rabavert |
| Blood testing | Procleix |
Disease & products
Learn about meningitis, influenza, rabies, TBE and japanese encephalities.
About Novartis Vaccines
Novartis Vaccines is the world's fifth-largest vaccines business.
Business Development & Licensing
Finding new partnership to develop new vaccines is one of the BD&L team mission.